Dr. Martens CEO signals confidence with share purchase
Dr. Martens’ Chief Executive Officer, Ije Nwokorie, has purchased 112,500 ordinary shares in the British footwear company, in a move that signals confidence in the brand’s direction. The total transaction value was around 85.6 thousand pounds (99.3 thousand euros).
The purchase follows the company’s latest annual results, which showed a return to profit growth despite a decline in revenue. In fiscal 2026, profit before tax rose by 9.7% to 32.7 million pounds (37.9 million euros), compared with 29.8 million pounds (33.5 million euros) a year earlier.
Revenue, however, fell by 1.5% over the same period, reaching 764.9 million pounds (887.8 million euros). The figures suggest that the company improved profitability even as sales remained under pressure.
Dr. Martens has described fiscal 2025 as a year of stabilisation, followed by a shift in fiscal 2026 towards a more consumer-first approach. After returning to profit growth, the company is now preparing to focus on scaling the business in fiscal 2027.
Nwokorie has acknowledged that further work remains in repositioning the business, but said the next stage of the strategy will centre on scaling. His share purchase adds confidence to that message.
1 GBP = 1.16 EUR
Image Credits: drapersonline.com